1. Home
  2. QRVO vs RGEN Comparison

QRVO vs RGEN Comparison

Compare QRVO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QRVO
  • RGEN
  • Stock Information
  • Founded
  • QRVO 1957
  • RGEN 1981
  • Country
  • QRVO United States
  • RGEN United States
  • Employees
  • QRVO N/A
  • RGEN N/A
  • Industry
  • QRVO Semiconductors
  • RGEN Medical/Dental Instruments
  • Sector
  • QRVO Technology
  • RGEN Health Care
  • Exchange
  • QRVO Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • QRVO 7.1B
  • RGEN 8.0B
  • IPO Year
  • QRVO 1997
  • RGEN N/A
  • Fundamental
  • Price
  • QRVO $85.28
  • RGEN $121.74
  • Analyst Decision
  • QRVO Hold
  • RGEN Buy
  • Analyst Count
  • QRVO 20
  • RGEN 12
  • Target Price
  • QRVO $89.84
  • RGEN $168.40
  • AVG Volume (30 Days)
  • QRVO 1.6M
  • RGEN 759.3K
  • Earning Date
  • QRVO 07-29-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • QRVO N/A
  • RGEN N/A
  • EPS Growth
  • QRVO N/A
  • RGEN N/A
  • EPS
  • QRVO 0.58
  • RGEN N/A
  • Revenue
  • QRVO $3,718,971,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • QRVO $0.65
  • RGEN $14.06
  • Revenue Next Year
  • QRVO $5.13
  • RGEN $14.33
  • P/E Ratio
  • QRVO $147.74
  • RGEN N/A
  • Revenue Growth
  • QRVO N/A
  • RGEN 4.88
  • 52 Week Low
  • QRVO $49.46
  • RGEN $102.97
  • 52 Week High
  • QRVO $124.87
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • QRVO 48.69
  • RGEN 48.77
  • Support Level
  • QRVO $86.19
  • RGEN $116.30
  • Resistance Level
  • QRVO $88.94
  • RGEN $125.00
  • Average True Range (ATR)
  • QRVO 2.08
  • RGEN 5.00
  • MACD
  • QRVO -0.65
  • RGEN -0.32
  • Stochastic Oscillator
  • QRVO 7.96
  • RGEN 44.03

About QRVO Qorvo Inc.

Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: